The financials
Beam Therapeutics Inc. by the numbers
Beam Therapeutics Inc. (BEAM) reported revenue of $490K in Q2 2026 (quarter ended June 30, 2026), down 94% from the same quarter a year earlier. That came with net loss of $123M. For the full year FY2025, revenue was $140M (+120% year on year) and net income −$80M.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $490K | $8.5M | −94% |
| Operating income | −$127M | −$120M | n/a |
| Net income | −$123M | −$102M | n/a |
| Diluted EPS | −$1.18 | −$1.00 | n/a |